Red Ginseng-containing diet helps to protect mice and ferrets from the lethal infection by highly pathogenic H5N1 influenza virus

다국어 초록 (Multilingual Abstract)

The highly pathogenic (HP) H5N1 influenza virus is endemic in many countries and has a great potential for a pandemic in humans. The immune-enhancing prowess of ginseng has been known for millennia. We aimed to study whether mice and ferrets fed with Red Ginseng could be better protected from the lethal infections of HP H5N1 influenza virus than the infected unfed mice and ferrets. We fed mice and ferrets with Red Ginseng prior to when they were infected with HP H5N1 influenza virus. The mice and ferrets fed with a 60-day diet containing Red Ginseng could be protected from lethal infections by HP H5N1 influenza virus (survival rate of up to 45% and 40%, respectively). Interferon-α and -γ antiviral cytokines were significantly induced in the lungs of mice fed Red Ginseng, compared to mice fed an unsupplemented diet. These data suggest that the diet with the immune-enhancing Red Ginseng could help humans to overcome the infections by HP H5N1 influenza virus.

목차 (Table of Contents)

• ABSTRACT
• 1. Introduction
• 2. Materials and methods
• 3. Results
• 4. Discussion
• References

참고문헌 (Reference)

1 Tran TH, "World Health Organization International Avian Influenza Investigative Team. Avian influenza A (H5N1) in 10 patients in Vietnam" 350 : 1179-1188, 2004

2 Schäfer JR, "Webster RG. Origin of the pandemic 1957 H2 influenza A virus and the persistence of its possible progenitors in the avian reservoir" 194 : 781-788, 1993

3 Kohlmeier JE, "Type I interferons regulate cytolytic activity of memory CD8þ T cells in the lung airways during respiratory virus challenge" 3 : 96-105, 2010

4 Kandun IN, "Three Indonesian clusters of H5N1 virus infection in 2005" 355 : 2186-2194, 2006

5 Kleiner SM, "The true nature of herbs" 23 : 13-14, 1995

6 Hatta M, "The continued pandemic threat posed by avian influenza viruses in Hong Kong" 10 : 340-344, 2002

7 Laver WG, "Studies on the origin of pandemic influenza. Evidence implicating duck and equine influenza viruses as possible progenitors of the Hong Kong strain of human influenza" 51 : 383-391, 1973

8 Treanor JJ, "Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine" 354 : 1343-1351, 2006

9 Meng S, "Recombinant chicken interferon-a inhibits H9N2 avian influenza virus replication in vivo by oral administration" 31 : 533-538, 2011

10 Liu CX, "Recent advances on ginseng research in China" 36 : 27-38, 1992

11 Hwang SD, "Protection of pregnant mice, fetuses and neonates from lethality of H5N1 influenza viruses by maternal vaccination" 28 : 2957-2964, 2010

12 Munster VJ, "Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets" 325 : 481-483, 2009

13 Kang YM, "Pandemic H1N1 influenza virus causes a stronger inflammatory response than seasonal H1N1 influenza virus in ferrets" 156 : 759-767, 2011

14 de Jong MD, "Oseltamivir resistance during treatment of influenza A (H5N1) infection" 353 : 2667-2672, 2005

15 Reid AH, "Origin and evolution of the 1918 'Spanish' influenza virus hemagglutinin gene" 96 : 1651-1656, 1999

16 Scholtissek C, "On the origin of the human influenza virus subtypes H2N2 and H3N2" 87 : 13-20, 1978

17 Akerele O, "Nature’s medicinal bounty: don’t throw it away" 14 : 390-395, 1993

18 Sung H, "Korean Red Ginseng slows depletion of CD4 T cells in human immunodeficiency virus type 1-infected patients" 12 : 497-501, 2005

19 Taubenberger JK, "Initial genetic characterization of the 1918 'Spanish' influenza virus" 275 : 1793-1796, 1997

20 Kim YH, "Influenza B virus causes milder pathogenesis and weaker inflammatory responses in ferrets than influenza A virus" 22 : 423-430, 2009

21 Singh VK, "Immunomodulatory activity of Panax ginseng extract" 50 : 462-465, 1984

22 Kenarova B, "Immunomodulating activity of ginsenoside Rg1 from Panax ginseng" 54 : 447-454, 1990

23 Zaman M, "Human infection with avian influenza virus, Pakistan, 2007" 17 : 1056-1059, 2001

24 Trevelyan J, "Herbal medicine" 89 : 36-38, 1993

25 Attele AS, "Ginseng pharmacology: multiple constituents and multiple actions" 58 : 1685-1693, 1999

26 Reid SM, "First reported incursion of highly pathogenic notifiable avian influenza A H5N1 viruses from clade 2.3.2 into European poultry" 58 : 76-78, 2011

27 de Jong MD, "Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma" 352 : 686-691, 2005

28 Vijaykrishna D, "Evolutionary dynamics and emergence of panzootic H5N1 influenza viruses" 4 : 1000161-, 2008

29 Webster RG, "Evolution and ecology of influenza A virus" 56 : 152-179, 1992

30 Song X, "Enhancement of immune responses to influenza vaccine (H3N2) by ginsenoside Re" 10 : 351-356, 2010

31 Petkov VD, "Effects of standardized ginseng extract on learning, memory and physical capabilities" 15 : 19-29, 1987

32 World Health Organization, "Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003-2013"

33 Yang L, "Compound Chinese herbal medicinal ingredients can enhance immune response and efficacy of RHD vaccine in rabbit" 26 : 4451-4455, 2008

34 Singh VK, "Combined treatment of mice with Panax ginseng extract and interferon inducer. Amplification of host resistance to Semliki forest virus" 47 : 234-236, 1983

35 Subbarao K, "Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness" 279 : 393-396, 1998

36 Fouchier RA, "Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls" 79 : 2814-2822, 2005

37 Ehrlich HJ, "Baxter H5N1 Pandemic Influenza Vaccine Clinical Study Team. A clinical trial of a whole-virus H5N1 vaccine derived from cell culture" 358 : 2573-2584, 2008

38 Kawaoka Y, "Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics" 63 : 4603-4608, 1989

39 Reed LJ, "A simple method of estimating fifty percent endpoints" 27 : 493-497, 1938

40 Shinde V, "A comparison of clinical and epidemiological characteristics of fatal human infections with H5N1 and human influenza viruses in Thailand, 2004-2006" 6 (6): 14809-, 2011